Dolibog Paweł T, Porębska Beata, Grzegorczyn Sławomir, Chmielewska Daria, Ślęzak Andrzej, Dolibog Patrycja
Department of Biophysics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 19 H. Jordan Str., 41-808 Zabrze, Silesia, Poland.
Department of Neurology with Stroke Subdepartment, Provincial Hospital in Bielsko-Biała, 101 Armii Krajowej Avenue, 43-316 Bielsko-Biała, Silesia, Poland.
J Clin Med. 2022 May 4;11(9):2571. doi: 10.3390/jcm11092571.
The available publications describing the beneficial effects of electrostimulation does not unequivocally confirm the clinical utility of high-voltage electrical stimulation (HVES) in the treatment of the lateral epicondylitis (LE). The aim of this study was the estimation of the effect of HVES on pain intensity and functional efficiency, both in the short and long term in patients with LE. The trial was registered by the Australian and New Zealand Clinical Trials Registry (ACTRN12621001389897). There were 58 patients allocated into two groups: the HVES group (n = 29, mean age 49.9 ± 11.0 years), treated with HVES (pulse duration: 200μs, frequency: 100 Hz, current amplitude in the range of 18-25 mA, voltage amplitude: 100 V), and the NORM group ( = 29, mean age 48.0 ± 12.6 years), who were healthy and untreated patients. The treatments were performed 5 days a week (from Monday to Friday) for two weeks. Treatment progress was measured by the visual analogue scale (VAS) for rest pain, night pain, and pain during activity; the Laitinen Pain Scale (LPS); and hand grip strength (HGS) before and after the treatment, as well as after 3, 6, 12, and 24 weeks. The reduction of pain (according to the VAS and LPS) and increase in the functional condition (according to the HGS) were observed in all HVES patients in the short- and long-term observation. Therefore, the HVES in treatment of LE was found to be effective and safe.
现有描述电刺激有益效果的出版物并未明确证实高压电刺激（HVES）在治疗外侧上髁炎（LE）中的临床效用。本研究的目的是评估HVES对LE患者短期和长期疼痛强度及功能效率的影响。该试验已在澳大利亚和新西兰临床试验注册中心（ACTRN12621001389897）注册。58名患者被分为两组：HVES组（n = 29，平均年龄49.9 ± 11.0岁），接受HVES治疗（脉冲持续时间：200μs，频率：100 Hz，电流幅度在18 - 25 mA范围内，电压幅度：100 V），以及NORM组（n = 29，平均年龄48.0 ± 12.6岁），该组为健康未治疗患者。治疗每周进行5天（从周一至周五），持续两周。通过视觉模拟量表（VAS）测量静息痛、夜间痛和活动时疼痛的治疗进展；Laitinen疼痛量表（LPS）；以及治疗前后、3周、6周、12周和24周后的握力（HGS）。在短期和长期观察中，所有HVES患者均观察到疼痛减轻（根据VAS和LPS）以及功能状况改善（根据HGS）。因此，发现HVES治疗LE有效且安全。
